Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum GW Pharmaceuticals Plc GWPHV

Bullboard (NDAQ:GWPHV)

View:
Comment by indaknownewfieon May 27, 2018 9:45pm

RE:RE:If GW Pharma gets CBD FDA approved...

Bought lots, totally undervalued and GW Pharma leading the way
Post by MoneyManager313on May 25, 2018 3:38pm

Guru predicts TBP (Aphria's Partner to Shine)

https://www.tradingview.com/chart/TBP/sSuB7EJj-Short-Medium-and-Long-term-BUY-for-gains-of-1000-percent/
Comment by serendipidyon May 24, 2018 5:09pm

RE:If GW Pharma gets CBD FDA approved...

kaly therapeutics ( kaly) is poised to skyrocket if CBD gains FDA approval.
Comment by TheMJkingon Apr 19, 2018 11:48am

RE:If GW Pharma gets CBD FDA approved...

 Isol as well. Would be a nice boost to the sector!
Post by bluesky1on Mar 28, 2018 2:31pm

Possible JV with Theralase Technologies (TLT.V; TLTFF)

Theralase discovered that their treatment combined to cannabinoid increases efficacity in destruction of brain cancer... They are also looking for JV.  
Post by truthseeker0420on Jan 01, 2018 7:58pm

InMed Board mentions GW takeover?

Just curios, is InMed a potential candidate for a GW takeover since InMed holds patent to replicate cannibannoids organically vs synthetically?
Post by Jonzeeeeeon Dec 31, 2017 7:17pm

If GW Pharma gets CBD FDA approved...

Imagine what companies like Revive Therapeutics(RVV 42 cents) would blast off to?
Comment by Tony501on Nov 18, 2017 7:25pm

RE:The future of THC and CBD .... symbol LDS

This company looks ready to take off!! Look at the You Tube videos just posted this week. They are planning on $30m in revenue in 2018. Manufacturing plant just completed in Oct. Looks like they are ...more  
Comment by ScreenName1on Nov 05, 2017 12:41pm

RE:Someone Explain this Company

I understand where you're coming from, I even place an order to sell half of my GW to purchase more LXRP. Then I came across this article and it looks like there could be a catalyst coming in ...more  
Post by Moszmoon Oct 30, 2017 9:29pm

Someone Explain this Company

Losing money hand over fist.  Valued so high, what gives ?   They have a pill coming out, so what ?  The industry is changing & there are oils & gelcaps available now for ...more  
Comment by TripleEmon Sep 18, 2017 11:07pm

RE:Check out TBP

https://tetrabiopharma.com/investors/press-releases/press-release-details/2017/Tetra-Bio-Pharma-getting-ready-to-file-a-clinical-trial-application-to-initiate-phase-3-clinical-trial-on-terminal-cancer ...more  
Post by TripleEmon Sep 18, 2017 10:34pm

Check out TBP

Great price, under valued, JMO, GLTA...
Post by Mangler85on Aug 25, 2017 4:57pm

I really like making money, TGIF

Has a strain naughty cookies that 34%thc. TGIF is selling weed in Nevada recreationally. TGIF is making a land purchase increasing operations about 6x. ( current facility can produce $300 000 USD a ...more  
Post by olivertwist2016on Aug 25, 2017 1:26pm

Check UMB

UMB is gone! 
Post by CBD420HEMPon Jun 19, 2017 8:46am

The next GWPH is ISOL

BREAKING NEWS!!!!!!! Isodiol International inc. commences approval process for its pharmaceutical products through the Brazilian Health Regulatory Agency (ANVISA)
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities